How many acquisitions has Recursion Pharmaceuticals made so far?

Recursion Pharmaceuticals has completed 4 acquisitions so far, with an average acquisition amount of $43.7M.

Which countries does Recursion Pharmaceuticals usually acquire in?

Recursion Pharmaceuticals has made acquisitions in 3 countries with the most activity in Canada and United Kingdom.

Which is Recursion Pharmaceuticals' latest acquisition?

Recursion Pharmaceuticals's most recent acquisition is Exscientia, a Provider of AI-driven drug discovery and precision medicine solutions, acquired in October 2024.

Which sectors does Recursion Pharmaceuticals target for acquisitions?

Most of Recursion Pharmaceuticals's acquisitions are in Life Sciences Tech (4) and Artificial Intelligence (3).

In which year did Recursion Pharmaceuticals make the most acquisitions?

Recursion Pharmaceuticals was most active in 2023, with 2 acquisitions completed in that year.

List of 4 Acquisitions by Recursion Pharmaceuticals (Apr 2026)

Recursion Pharmaceuticals has completed 4 acquisitions. These acquisitions span 5 sectors, including Life Sciences Tech, Artificial Intelligence, and Oncology, and were made in 3 countries: Canada, United Kingdom, and United States. Peak acquisition years include 2023 with 2 acquisitions, 2024 with 1 acquisition, and 2020 with 1 acquisition. Over the last five years (2020-2025), the average number of acquisitions per year stands at 0.6. There have been 0 acquisitions completed in the current calendar year so far. The most recent acquisition was Exscientia, a company founded in 2012 in Oxford that provides AI-driven drug discovery and precision medicine solutions. This acquisition took place in October, 2024.

Here's the year on year acquisition history of Recursion Pharmaceuticals:

Number of Total Acquisitions

Year	# Acquisitions
2024	1
2023	2
2020	1

View all Acquisitions by Recursion Pharmaceuticals

Recent acquisitions by Recursion Pharmaceuticals

Recursion Pharmaceuticals's most recent acquisition - Exscientia is a Provider of AI-driven drug discovery and precision medicine solutions, founded in 2012 and located in Oxford. Recursion Pharmaceuticals acquired it in October 2024 for a price of $*****.

Here is the list of all acquisitions by Recursion Pharmaceuticals sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Oct 10, 2024	Exscientia	xejj	xhja	95	515
May 08, 2023	Valence Labs	dtkk	zzg{	45	540
May 08, 2023	Cyclica	imlr	gecv	94	134

View the full list of acquisitions

Media has covered Recursion Pharmaceuticals for a total of 23 events in the last 1 year, 2 of them have been about acquisition activity.

•

Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for REV102intelligence360•Sep 22, 2025•Recursion Pharmaceuticals, Rallybio

•

Rallybio Sells REV102 Program Interest to Recursion PharmaceuticalsBusiness Wire•Jul 08, 2025•Rallybio, Recursion Pharmaceuticals

View More Recursion Pharmaceuticals Recent News

View all Acquisitions by Recursion Pharmaceuticals

Acquisitions by Recursion Pharmaceuticals

List of Recursion Pharmaceuticals's Acquisitions

Recent acquisitions by Recursion Pharmaceuticals

News related to Recursion Pharmaceuticals's acquisitions

FAQs about Acquisitions by Recursion Pharmaceuticals